<?xml version="1.0" encoding="UTF-8"?>
<ref id="B36-ijerph-17-04951">
 <label>36.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Martinello</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Bartlett</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Dore</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Bopage</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Finlayson</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Baker</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Matthews</surname>
    <given-names>G.</given-names>
   </name>
  </person-group>
  <article-title>Universal access to DAA therapy paves theway for HCV control and elimination among people living with HIV in Australia</article-title>
  <source>J. Hepatol.</source>
  <year>2018</year>
  <volume>68</volume>
  <issue>Suppl. 1</issue>
  <fpage>S312</fpage>
  <lpage>S313</lpage>
  <pub-id pub-id-type="doi">10.1016/S0168-8278(18)30843-2</pub-id>
 </element-citation>
</ref>
